• Wednesday: Genetic strategy for clopidogrel dosing (ELEVATE-TIMI 56), COPPS, EASE, CLEVER and more
• Tuesday: Tuesday's late-breaking clinical trials, prevention of ischemic heart disease events – obesity, hypertension, hyperlipidemia
• Monday: Monday's late-breaking trials, SCIPIO interim results and more
• Sunday: Reduction in adverse event risk with rivaroxaban + standard care: ATLAS ACS-TIMI 51
• Saturday: Therapeutic hypothermia, predicting and improving survival after out-of-hospital cardiac arrest, adenocaine/magnesium for hemorrhage

Scientific Sessions 2011 Video Previews

English	Japanese

MD Conference Express
For an authoritative reference of the key findings from Sessions 2011 - we invite you to read the official peer-reviewed highlights report .
Clinical trial highlights in this issue include results from the ATLAS ACS 2-TIMI 51, TRA•CER, AIM HIGH, PALLAS and MI FREEE trials. This issue also examines strategies for complex valvular disease, new transcatheter valve technologies and techniques, how imaging can be best used to determine cardiovascular risk and peripheral arterial disease.